Check out our featured webcasts from BioPharm International®! #Biologics #Formulation
BioPharm International
Book and Periodical Publishing
Iselin, NJ 1,861 followers
Talking biopharmaceuticals, biotechnology, bioprocessing and related pharma manufacturing.
About us
BioPharm International integrates the science and business of biopharmaceutical development, and manufacturing. We provide practical, peer-reviewed technical articles to enable biopharmaceutical professionals to perform their jobs more effectively. We believe that technical decisions are also business decisions and give readers the tools to make both sound business and technical decisions.
- Website
-
http://www.biopharminternational.com
External link for BioPharm International
- Industry
- Book and Periodical Publishing
- Company size
- 501-1,000 employees
- Headquarters
- Iselin, NJ
- Type
- Privately Held
Locations
-
Primary
485F US Hwy 1 South, Ste. 210
Iselin, NJ 08830-3009, US
Employees at BioPharm International
Updates
-
From the top to the bottom, discover SCIEX solutions for biotherapeutic characterization and development Learn strategies to address the unexpected in Cell Line Development! Learn more: https://ow.ly/gQNH50Tm1WI
-
In this episode of the Ask the Expert video series, Peter Walters, CRB Group, discusses factors to be considered in constructing a new facility for cell and gene therapy production as well as using an existing facility to expand cell and gene therapy pipelines. https://lnkd.in/e2G5vxJb
Cell and Gene Therapy Production Facilities
biopharminternational.com
-
Robust Oligonucleotide Molecular Weight Confirmation by LC-MS This webcast will cover molecular weight confirmation of oligonucleotides by LC/MS, focusing on the use of fit-for-purpose deconvolution software. Register now: https://ow.ly/8Xpm50TukiP
-
Navigating the Biologics CDMO Landscape We’d like to offer you exclusive access to an online resource with useful tools and practical information on navigating the biologics CDMO landscape. Access all resources: https://ow.ly/ZOp450ToC7B
-
In this episode of the Ask the Expert video series, Peter Walters, CRB Group, discusses factors to be considered in constructing a new facility for cell and gene therapy production as well as using an existing facility to expand cell and gene therapy pipelines. https://lnkd.in/e2G5vxJb
Cell and Gene Therapy Production Facilities
biopharminternational.com
-
In this episode of the Ask the Expert video series, Peter Walters, CRB Group, discusses factors to be considered in constructing a new facility for cell and gene therapy production as well as using an existing facility to expand cell and gene therapy pipelines. https://lnkd.in/e2G5vxJb
Cell and Gene Therapy Production Facilities
biopharminternational.com
-
BioPharm International reposted this
Snippets of conversation from the Hanson Wade Group 9th Annual CAR-T/TCR conference happening in Boston yesterday and today. Lots of energy plus great scientific posters and presentations. BIG thanks to Ellie Saunders Scott Pattison Sean Hart, PhD Renee A. Hart Marty Flanagan James Bailey Junxia W. uBriGene Biosciences Inc. LumaCyte AIT Worldwide Logistics Catalent Pharma Solutions also a shoutout to the interesting conversations I had with Francis Y. Jason Hunyar Lisa Glendinning Shashi Koduru BioPharm International Pharmaceutical Technology and many many others. #cart #cgt #atmp #biopharma #cell
-
BioPharm International reposted this
"Beyond paydirt" of continuous manufacturing of mRNA drug products, discussion here:https://lnkd.in/e57Y6Suf Aaron B Cowley of ReciBioPharm updates results from the Peter Marks led initiative at MIT to optimize #mRNA manufacture. Cowely stated that “being able to have eyes on the process, and the product, as it goes along the full train of manufacturing, and being able to release that data in real-time, that is the overall goal.” When addressing potential scale-up bottlenecks or other obstacles, particularly on the analytical side, Cowely went on to say, “the beauty of this grant is that we are able to take the best technologies, regardless of company source, and incorporate them, to see what’s working and what’s not work[ing] [for continuos manufacture]. After a year and a half, we already have a process development system that’s capable of going from [IVT] through [to] fill/finish, fully operational, so we’re collecting data. We have the process analytical technology (PAT) that’s actually driving the process already. We can see the kinetics of the process. We can see the impurity profile. We can take the material and send it to waste, if it's not meeting criteria, or move it ahead to the next unit operation … we’ve been using off-the-shelf PAT equipment, but not in the way it’s been traditionally deployed.” a nod to Massachusetts Institute of Technology FDA Richard D. Braatz Andrew Zydney Steven Cramer Todd Przybycien Paula Hammond Cunningham Allan Myerson Pharmaceutical Technology MJH Life Sciences® #pharmamanufactring #atmp #vaccine #pandemic #biologic
-
SK pharmteco and Cryoport are partnering to provide logistics and manufacturing services to biotechnology and pharma companies.https://https://lnkd.in/eKXhiYJ8
SK pharmteco and Cryoport Collaborate on Cell and Gene Therapies
biopharminternational.com